NO20050346D0 - Nitro-oksyderivater av syklooksygenase-2-inhibitorer - Google Patents
Nitro-oksyderivater av syklooksygenase-2-inhibitorerInfo
- Publication number
- NO20050346D0 NO20050346D0 NO20050346A NO20050346A NO20050346D0 NO 20050346 D0 NO20050346 D0 NO 20050346D0 NO 20050346 A NO20050346 A NO 20050346A NO 20050346 A NO20050346 A NO 20050346A NO 20050346 D0 NO20050346 D0 NO 20050346D0
- Authority
- NO
- Norway
- Prior art keywords
- cyclooxygenase
- inhibitors
- nitric oxide
- oxide derivatives
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/46—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms
- C07C323/49—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms to sulfur atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Heart & Thoracic Surgery (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2002MI001391A ITMI20021391A1 (it) | 2002-06-25 | 2002-06-25 | Nitroderivati di inibitori della cicloossigenasi-2 |
PCT/EP2003/006502 WO2004000781A2 (en) | 2002-06-25 | 2003-06-20 | Nitrooxyderivatives of cyclooxygenase-2 inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20050346D0 true NO20050346D0 (no) | 2005-01-21 |
NO20050346L NO20050346L (no) | 2005-02-28 |
Family
ID=11450078
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20050346A NO20050346L (no) | 2002-06-25 | 2005-01-21 | Nitro-oksyderivater av syklooksygenase-2-inhibitorer |
Country Status (16)
Country | Link |
---|---|
US (1) | US7776902B2 (no) |
EP (1) | EP1517889A2 (no) |
JP (1) | JP4445854B2 (no) |
CN (1) | CN100516037C (no) |
AU (1) | AU2003245972B2 (no) |
CA (1) | CA2491209A1 (no) |
HK (1) | HK1080069A1 (no) |
IL (1) | IL165475A0 (no) |
IT (1) | ITMI20021391A1 (no) |
MX (1) | MXPA04012851A (no) |
NO (1) | NO20050346L (no) |
NZ (1) | NZ537043A (no) |
PL (1) | PL374279A1 (no) |
RU (1) | RU2339617C2 (no) |
WO (1) | WO2004000781A2 (no) |
ZA (1) | ZA200410060B (no) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7220749B2 (en) | 2002-06-11 | 2007-05-22 | Nitromed, Inc. | Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
US20060003996A1 (en) * | 2002-06-17 | 2006-01-05 | Stephen Roth | Intralesional treatment of psoriasis |
AU2003247622A1 (en) | 2002-06-27 | 2004-01-19 | Nitromed, Inc. | Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
EP1527045A1 (en) | 2002-07-26 | 2005-05-04 | Merck Frosst Canada & Co. | Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors |
EP1562914A1 (en) * | 2002-10-22 | 2005-08-17 | Merck Frosst Canada & Co. | Nitric oxide releasing selective cyclooxygenase-2 inhibitors |
JP4425921B2 (ja) | 2003-03-05 | 2010-03-03 | メルク フロスト カンパニー | シクロオキシゲナーゼ−2インヒビターとして作用するジアリール2−(5h)−フラノンの酸化窒素放出プロドラッグ |
EP1789091B1 (en) | 2004-08-26 | 2010-08-25 | Piramal Life Sciences Limited | Prodrugs containing novel bio-cleavable linkers |
TW200616604A (en) | 2004-08-26 | 2006-06-01 | Nicholas Piramal India Ltd | Nitric oxide releasing prodrugs containing bio-cleavable linker |
US7521435B2 (en) | 2005-02-18 | 2009-04-21 | Pharma Diagnostics, N.V. | Silicon containing compounds having selective COX-2 inhibitory activity and methods of making and using the same |
US7807716B2 (en) * | 2008-09-24 | 2010-10-05 | Oral Delivery Technology Ltd. | Nitric oxide amino acid ester compound, compositions for increasing nitric oxide levels and method of use |
CN105358174B (zh) | 2013-03-15 | 2019-03-15 | 酵活有限公司 | 具细胞毒性和抗有丝***的化合物以及其使用方法 |
US9889145B2 (en) * | 2013-04-23 | 2018-02-13 | The Administrators Of The Tulane Educational Fund | Methods to treat infections |
US10675355B2 (en) | 2013-12-27 | 2020-06-09 | Var2 Pharmaceuticals Aps | VAR2CSA-drug conjugates |
PL3086815T3 (pl) * | 2013-12-27 | 2022-06-13 | Zymeworks Inc. | Układy łącznikowe dla koniugatów leków zawierające ugrupowanie sulfonamidowe |
BR112016016386B1 (pt) | 2014-01-14 | 2023-02-23 | Euclises Pharmaceuticals, Inc | Composto ou um sal ou solvato do mesmo, composição farmacêutica e uso de um composto na preparação de um medicamento |
WO2016041082A1 (en) | 2014-09-17 | 2016-03-24 | CDRD Ventures, Inc. | Cytotoxic and anti-mitotic compounds, and methods of using the same |
CN105503883B (zh) * | 2015-12-30 | 2018-03-02 | 西安交通大学 | 一类西格列汀‑硝酸酯杂合体及其制备方法和应用 |
CN110396064B (zh) * | 2019-07-25 | 2020-07-10 | 南京大学 | 甲磺酰胺衍生物及其制备方法和防治阿尔茨海默病的应用 |
CN112898201A (zh) * | 2021-01-21 | 2021-06-04 | 南京理工大学 | 硝酸酯化合物以及合成吡啶亚砜亚胺导向的c-h硝酸酯化的方法 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3840597A (en) | 1971-02-24 | 1974-10-08 | Riker Laboratories Inc | Substituted 2-phenoxy alkane-sulfonanilides |
US5604260A (en) | 1992-12-11 | 1997-02-18 | Merck Frosst Canada Inc. | 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2 |
US5700947A (en) | 1993-10-06 | 1997-12-23 | Nicox S.A. | Nitric esters having anti-inflammatory and/or analgesic activity and process for their preparation |
US5466823A (en) | 1993-11-30 | 1995-11-14 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides |
SI0759899T1 (en) | 1994-05-10 | 1999-12-31 | Nicox S.A. | Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic acitivities |
EP0788476B1 (en) * | 1994-10-27 | 1999-10-20 | Merck Frosst Canada & Co. | Stilbene derivatives useful as cyclooxygenase-2 inhibitors |
FI945082A0 (fi) * | 1994-10-28 | 1994-10-28 | Risto Nikander | Foerfarande och anordning foer justering av glashaerdningshuvudet |
JP3181190B2 (ja) * | 1994-12-20 | 2001-07-03 | 日本たばこ産業株式会社 | オキサゾール誘導体 |
JP2636819B2 (ja) | 1994-12-20 | 1997-07-30 | 日本たばこ産業株式会社 | オキサゾール系複素環式芳香族化合物 |
RU2200158C2 (ru) | 1995-02-13 | 2003-03-10 | Джи.Ди.Сирл энд Ко. | Замещенные изоксазолы, фармацевтические композиции на их основе и способ подавления воспалений |
IT1288123B1 (it) | 1996-09-04 | 1998-09-10 | Nicox Sa | Uso di nitroderivati per l'incontinenza urinaria |
CO4960662A1 (es) | 1997-08-28 | 2000-09-25 | Novartis Ag | Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados |
IT1308633B1 (it) | 1999-03-02 | 2002-01-09 | Nicox Sa | Nitrossiderivati. |
IT1311924B1 (it) | 1999-04-13 | 2002-03-20 | Nicox Sa | Composti farmaceutici. |
IT1311923B1 (it) | 1999-04-13 | 2002-03-20 | Nicox Sa | Composti farmaceutici. |
EP1246621A4 (en) | 1999-12-23 | 2004-11-24 | Nitromed Inc | NITROSED AND NITROSYLATED CYCLOOXYGENASE-2 INHIBITORS, COMPOSITIONS AND METHODS FOR THEIR USE |
IT1319202B1 (it) * | 2000-10-12 | 2003-09-26 | Nicox Sa | Farmaci per le malattie a base infiammatoria. |
-
2002
- 2002-06-25 IT IT2002MI001391A patent/ITMI20021391A1/it unknown
-
2003
- 2003-06-20 CN CNB038146827A patent/CN100516037C/zh not_active Expired - Fee Related
- 2003-06-20 CA CA002491209A patent/CA2491209A1/en not_active Abandoned
- 2003-06-20 AU AU2003245972A patent/AU2003245972B2/en not_active Expired - Fee Related
- 2003-06-20 NZ NZ537043A patent/NZ537043A/en unknown
- 2003-06-20 IL IL16547503A patent/IL165475A0/xx unknown
- 2003-06-20 EP EP03738069A patent/EP1517889A2/en not_active Withdrawn
- 2003-06-20 JP JP2004514803A patent/JP4445854B2/ja not_active Expired - Fee Related
- 2003-06-20 WO PCT/EP2003/006502 patent/WO2004000781A2/en active Application Filing
- 2003-06-20 RU RU2004138552/04A patent/RU2339617C2/ru not_active IP Right Cessation
- 2003-06-20 PL PL03374279A patent/PL374279A1/xx not_active Application Discontinuation
- 2003-06-20 MX MXPA04012851A patent/MXPA04012851A/es not_active Application Discontinuation
- 2003-06-20 US US10/516,938 patent/US7776902B2/en not_active Expired - Fee Related
-
2004
- 2004-12-13 ZA ZA200410060A patent/ZA200410060B/en unknown
-
2005
- 2005-01-21 NO NO20050346A patent/NO20050346L/no not_active Application Discontinuation
-
2006
- 2006-01-04 HK HK06100164.4A patent/HK1080069A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
JP2005530836A (ja) | 2005-10-13 |
IL165475A0 (en) | 2006-01-15 |
EP1517889A2 (en) | 2005-03-30 |
US20060106082A1 (en) | 2006-05-18 |
ITMI20021391A1 (it) | 2003-12-29 |
US7776902B2 (en) | 2010-08-17 |
MXPA04012851A (es) | 2005-02-24 |
RU2339617C2 (ru) | 2008-11-27 |
AU2003245972B2 (en) | 2009-09-17 |
WO2004000781A2 (en) | 2003-12-31 |
CN100516037C (zh) | 2009-07-22 |
WO2004000781A3 (en) | 2004-10-14 |
NO20050346L (no) | 2005-02-28 |
ZA200410060B (en) | 2005-10-20 |
PL374279A1 (en) | 2005-10-03 |
CN1662490A (zh) | 2005-08-31 |
HK1080069A1 (zh) | 2006-04-21 |
RU2004138552A (ru) | 2005-10-20 |
ITMI20021391A0 (it) | 2002-06-25 |
AU2003245972A1 (en) | 2004-01-06 |
JP4445854B2 (ja) | 2010-04-07 |
NZ537043A (en) | 2006-09-29 |
CA2491209A1 (en) | 2003-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20050346D0 (no) | Nitro-oksyderivater av syklooksygenase-2-inhibitorer | |
CY2013043I1 (el) | Ενωσεις 4-οξοκινολινης και χρησιμοποιηση αυτων ως αναστολεις της ενσωματασης του hiv | |
NO20054880D0 (no) | Azaspiroalkanderivater som inhibitorer av metallproeaser | |
IS6934A (is) | Nýjar spírótrísýklískar afleiður og notkun þeirrasem fosfódíesterasa-7-hindrar | |
NO20043726L (no) | Heteroarylforbindelser anvendelige som inhibitorer av GSK-3 | |
CY2011016I2 (el) | Λακταμουχες ενωσεις και παραγωγα αυτων ως αναστολεις του παραγοντα χα | |
NO20054260D0 (no) | Disepergebar formulering av en anti-inflammatorisk forbindelse | |
DE60221977D1 (de) | Pro-pharmakon von cox-2-inhibitoren | |
DK1532145T3 (da) | Pyrazolpræparater der er anvendelige som inhibitorer af GSK-3 | |
CY2017048I1 (el) | Νεες φαρμακευτικες χρησεις των παραγωγων σταυροσπορινης | |
FI20030326A (fi) | Datan syöttö | |
NO20044113L (no) | Inhibitorer av histon-deacetylase | |
DE602004016970D1 (de) | P38 inhibitor und anwendungsverfahren dafür | |
NO20043158L (no) | Substituerte kinazolinderivater som inhibitorer av aurorakinaser | |
DK1501508T3 (da) | Inhibitorer af histondeatylase | |
NO20050072L (no) | Nye inhibitorer av kinaser | |
IS7792A (is) | Hýdantóínafleiður og notkun þeirra sem TACE hemla | |
IS2914B (is) | Kínólín afleiður og notkun þeirra sem tálma sveppagerla | |
NO20031139L (no) | 2-amino-2-alkyl-4-heksen- og heksynsyrederivater som er anvendbare som nitrogenoksidsyntaseinhibitorer | |
NO20044916L (no) | Preparater av sulfinylacetamid | |
AU2003278039A1 (en) | Nitric oxide releasing selective cyclooxygenase-2 inhibitors | |
NO20054188D0 (no) | Et arrangement av fagverksstag | |
DK1317421T3 (da) | 2-amino-2-alkyl-5-heptensyre- og heptynsyrederivater der er nyttige som nitrogenoxidsynthaseinhibitorer | |
NO20041938L (no) | Anvendelse av fosfodiesterase IV-inhibitorer | |
IS7963A (is) | Efnasambönd með hamlandi virkni gegn prólýlólígópeptíðasa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |